7th ACCP Conference on Antithrombotic and Thrombolytic Therapy:

1
7th ACCP Conference on Antithrombotic and
Thrombolytic Therapy

• Evidence-Based Guidelines

2
Grade 1 Recommendations
RCT randomized controlled trial
3
Grade 2 Recommendations
RCT randomized controlled trial
4
Pregnant Patients
5
Terms Used in This Section
6
Terms Used in This Section, continued
q12h dosing is preferable, at least initially,
because the half-life of LMWH is shorter during
pregnancy
7
Terms Used in This Section, continued
8
Treatment of VTE
9
Prevention of VTE
10
Prevention of VTE, continued
11
Prevention of VTE, continued
12
Prevention of VTE, continued
13
Prophylactic Therapy in Patients at Increased
Risk of Pregnancy Loss
14
Prophylactic Therapy in Patients at Increased
Risk of Pregnancy Loss, cont'd
These women are at increased risk of venous
thrombosis and perhaps pregnancy loss.